Abstract
Background:
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce surgical risks through metabolic and anti-inflammatory benefits, but their evidence in spine surgery remains mixed.
Purpose:
We sought to compare postoperative outcomes and healthcare use after lumbar discectomy between GLP-1 RA users and 2 control cohorts: obese and normal body mass index (BMI) patients.
Methods:
Adults with lumbar disk herniation undergoing single-level discectomy (2010-2023) were identified in the PearlDiver database. Three cohorts were created: (1) GLP-1 RA users (N = 540); (2) obese controls (N = 63 445); and (3) normal-BMI controls (N = 96,965). After propensity score matching (PSM), 539 GLP-1 RA users were matched with 539 obese controls on age, sex, Charlson Comorbidity Index (CCI), diabetes mellitus, and tobacco use. Two-tailed t-tests and χ2 tests were performed for pairwise comparisons between unmatched and matched GLP-1 RA users and obese controls.
Results:
Compared to obese controls, GLP-1 RA users demonstrated lower rates of 90-day medical complications, such as pneumonia, that persisted after PSM, and lower rates of 90-day emergency department visits before and after PSM. In addition, GLP-1 RA users demonstrated lower rates of hospital readmissions compared to obese controls, before and after PSM. GLP-1 RA users incurred higher total 90-day costs, but this did not persist after PSM. While GLP-1 RA users had higher 2-year revision discectomy rates than matched obese controls (4.1% vs 2.4%), this difference was not statistically significant.
Conclusion:
After PSM on demographics and select comorbidities, preoperative GLP-1 RA exposure was associated with lower 90-day medical complications, unplanned ED visits, and readmissions following single-level lumbar discectomy compared to obese controls. Revision discectomy and lumbar fusion rates were not significantly different after matching. Future research is needed to guide perioperative management of GLP-1 RA medications.
Level of Evidence:
Level III, Retrospective comparative cohort study
Keywords
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
